Impact of Hemodialysis on Cutaneo-muscular Electrical Impedance

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04892745

Acronym

H-ICMUS

Enrollment

Registered

2021-05-19

Start date

2021-09-29

Completion date

2022-05-25

Last updated

2025-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodialysis

Keywords

hemodialysis, electrical impedance, subcutaneous impedancemetry, cutaneo-muscular impedancemetry

Brief summary

The primary objective of this pilot study aims to describe the modifications of subcutaneous impedancemetry induced by dialysis. As secondary objectives, the study aims to 1) describe the modifications of cutaneo-muscular impedancemetry induced by dialysis. 2) describe the relationship between modifications of subcutaneous impedancemetry induced by dialysis and - technical conditions of dialysis; - volemic parameters of dialysis; - evolution of liquid compartments in organism during dialysis; - volemic events or neuromuscular events. 3) describe the relationship between modifications of cutaneo-muscular impedancemetry induced by dialysis and 1) describe the modifications of cutaneo-muscular impedance induced by dialysis. 2) describe the relationship between modifications of subcutaneous impedancemetry induced by dialysis and - technical conditions of dialysis; - volemic parameters of dialysis; - evolution of liquid compartments in organism during dialysis; - volemic events or neuromuscular events.

Detailed description

The study will be realized in dialysis facility of Ambroise Paré hospital, APHP. The duration of enrollment of subjects will be 3 months, each enrolled patient will has 2 or 3 week's follow-up.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 89 Years

Healthy volunteers

Inclusion criteria

* Patient ⩾ 18 years; * Patient undergoing chronic dialysis in hemodialysis facility of Ambroise Paré hospital; * Patient has been informed and given no-opposition for participating to the study.

Exclusion criteria

* Patient with a pacemaker or an implantable cardioverter defibrillator; * Patient under guardianship or curatorship; * Foreign patient under french AME scheme.

Design outcomes

Primary

Measure	Time frame	Description
Electrical parameters of subcutaneous impedancemetry	at the end of study, up to 4 months	Electrical parameter extracellular resistance (Re) will be assessed.

Secondary

Measure	Time frame	Description
Cutaneo-muscular impedancemetry assessement	at the end of study, up to 4 months	Cutaneo-muscular impedancemetry will be assessed by extracellular resistance (Re).
Whole body impedancemetry assessement	at the end of study, up to 4 months	Whole body impedancemetry will be assessed by Re.
Incidence of volemic or neuromuscular events	at the end of study, up to 4 months	Incidence of volemic or neuromuscular events during the session, such as: * peridialytic hypotension, * crampses.

Countries

France

Outcome results